The University of Southampton
University of Southampton Institutional Repository

Microglial contribution to synaptic uptake in the prefrontal cortex in schizophrenia

Microglial contribution to synaptic uptake in the prefrontal cortex in schizophrenia
Microglial contribution to synaptic uptake in the prefrontal cortex in schizophrenia
Microglia in human post-mortem tissue in schizophrenia patients' brains engulf synaptic material, but not differently to age-matched non-neurological control brains. Also, schizophrenia brains display similar levels of microgliosis to control brains.
0305-1846
346-351
Tzioras, Makis
aa148ee3-f660-4075-a840-1e4b6337bfa3
Stevenson, Anna J.
778b7487-eb57-4e25-895e-41c266d0866f
Boche, Delphine
bdcca10e-6302-4dd0-919f-67218f7e0d61
Spires-Jones, Tara L.
f06b279e-bcd0-4bed-850b-fad5db996019
Tzioras, Makis
aa148ee3-f660-4075-a840-1e4b6337bfa3
Stevenson, Anna J.
778b7487-eb57-4e25-895e-41c266d0866f
Boche, Delphine
bdcca10e-6302-4dd0-919f-67218f7e0d61
Spires-Jones, Tara L.
f06b279e-bcd0-4bed-850b-fad5db996019

Tzioras, Makis, Stevenson, Anna J., Boche, Delphine and Spires-Jones, Tara L. (2021) Microglial contribution to synaptic uptake in the prefrontal cortex in schizophrenia. Neuropathology and Applied Neurobiology, 47 (2), 346-351. (doi:10.1111/nan.12660).

Record type: Article

Abstract

Microglia in human post-mortem tissue in schizophrenia patients' brains engulf synaptic material, but not differently to age-matched non-neurological control brains. Also, schizophrenia brains display similar levels of microgliosis to control brains.

Text
NAN SZ manuscript Correspondence v2 - Accepted Manuscript
Download (60kB)

More information

Accepted/In Press date: 22 August 2020
e-pub ahead of print date: 6 September 2020
Published date: 1 February 2021
Additional Information: Funding Information: We would like to thank our funders, specifically the UK Dementia Research Institute which receives funding from Alzheimer?s Research UK, the Alzheimer?s Society, and the Medical Research Council. We also would like to thank the Wellcome Trust for funding AJS and TLSJ. Tissue samples were obtained from The Corsellis Collection as part of the UK Brain Archive Information Network (BRAIN UK) which is funded by the Medical Research Council and Brain Tumour Research. Ethics approval was provided by BRAIN UK, a virtual brain bank which encompasses the archives of neuropathology departments in the UK and the Corsellis Collection, ethics reference 14/SC/0098. The study was registered under the Ethics and Research Governance (ERGO) of the Southampton University (Reference 19791). Authors contributed in the following ways: MT contributed to the study design, performed experiments and imaging, statistical analysis and manuscript preparation; AJS contributed to statistical analysis and manuscript editing; DB contributed by providing cut paraffin-embedded section, study design and manuscript editing; TLSJ contributed the study design, statistical analysis and manuscript editing. TLSJ is on the Scientific Advisory Board of Cognition Therapeutics and receives collaborative grant funding from two industry partners. None of these had any influence over this paper. None of remaining authors declare any conflicts of interest. Figures were created with BioRender.com. Funding Information: We would like to thank our funders, specifically the UK Dementia Research Institute which receives funding from Alzheimer’s Research UK, the Alzheimer’s Society, and the Medical Research Council. We also would like to thank the Wellcome Trust for funding AJS and TLSJ. Tissue samples were obtained from The Corsellis Collection as part of the UK Brain Archive Information Network (BRAIN UK) which is funded by the Medical Research Council and Brain Tumour Research. Ethics approval was provided by BRAIN UK, a virtual brain bank which encompasses the archives of neuropathology departments in the UK and the Corsellis Collection, ethics reference 14/SC/0098. The study was registered under the Ethics and Research Governance (ERGO) of the Southampton University (Reference 19791). Authors contributed in the following ways: MT contributed to the study design, performed experiments and imaging, statistical analysis and manuscript preparation; AJS contributed to statistical analysis and manuscript editing; DB contributed by providing cut paraffin‐embedded section, study design and manuscript editing; TLSJ contributed the study design, statistical analysis and manuscript editing. TLSJ is on the Scientific Advisory Board of Cognition Therapeutics and receives collaborative grant funding from two industry partners. None of these had any influence over this paper. None of remaining authors declare any conflicts of interest. Figures were created with BioRender.com.

Identifiers

Local EPrints ID: 443455
URI: http://eprints.soton.ac.uk/id/eprint/443455
ISSN: 0305-1846
PURE UUID: 7066f376-4b32-4187-a4a7-a90f6e1adabe
ORCID for Delphine Boche: ORCID iD orcid.org/0000-0002-5884-130X

Catalogue record

Date deposited: 26 Aug 2020 16:34
Last modified: 17 Mar 2024 02:51

Export record

Altmetrics

Contributors

Author: Makis Tzioras
Author: Anna J. Stevenson
Author: Delphine Boche ORCID iD
Author: Tara L. Spires-Jones

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×